Lindbrook Capital, LLC Fate Therapeutics Inc Transaction History

Lindbrook Capital, LLC

  • $1.18 Billion
  • Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 260 shares of FATE stock, worth $595. This represents 0.0% of its overall portfolio holdings.

Number of Shares
260
Previous 537 51.58%
Holding current value
$595
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$3.12 - $5.57 $864 - $1,542
-277 Reduced 51.58%
260 $0
Q2 2024

Jul 31, 2024
SELL
$3.26 - $7.08 $821 - $1,784
-252 Reduced 31.94%
537 $1,000
Q1 2024

Apr 25, 2024
BUY
$3.54 - $8.35 $1,175 - $2,772
332 Added 72.65%
789 $5,000
Q4 2023

Jan 31, 2024
BUY
$1.65 - $3.94 $754 - $1,800
457 New
457 $1,000
Q1 2023

Apr 26, 2023
BUY
$4.24 - $11.12 $4,583 - $12,020
1,081 Added 331.6%
1,407 $8,000
Q4 2022

Jan 24, 2023
BUY
$9.86 - $23.83 $1,173 - $2,835
119 Added 57.49%
326 $0
Q3 2022

Nov 10, 2022
SELL
$21.04 - $36.06 $589 - $1,009
-28 Reduced 11.91%
207 $5,000
Q2 2022

Aug 01, 2022
BUY
$17.78 - $42.39 $800 - $1,907
45 Added 23.68%
235 $6,000
Q1 2022

Apr 21, 2022
SELL
$29.67 - $60.28 $10,859 - $22,062
-366 Reduced 65.83%
190 $7,000
Q4 2021

Jan 18, 2022
BUY
$47.84 - $64.34 $24,876 - $33,456
520 Added 1444.44%
556 $33,000
Q2 2021

Jul 27, 2021
SELL
$67.25 - $92.52 $2,219 - $3,053
-33 Reduced 47.83%
36 $3,000
Q1 2021

Apr 28, 2021
BUY
$72.16 - $117.4 $2,381 - $3,874
33 Added 91.67%
69 $6,000
Q4 2020

Jan 27, 2021
BUY
$38.09 - $100.95 $914 - $2,422
24 Added 200.0%
36 $3,000
Q3 2020

Nov 03, 2020
SELL
$30.41 - $40.5 $15,205 - $20,250
-500 Reduced 97.66%
12 $0
Q2 2020

Jul 27, 2020
BUY
$20.21 - $35.23 $9,478 - $16,522
469 Added 1090.7%
512 $18,000
Q1 2020

Apr 22, 2020
SELL
$17.28 - $31.88 $33,816 - $62,389
-1,957 Reduced 97.85%
43 $1,000
Q4 2019

Jan 27, 2020
BUY
$13.39 - $20.73 $26,780 - $41,460
2,000 New
2,000 $39,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $222M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email